1. Home
  2. VGZ vs SIGA Comparison

VGZ vs SIGA Comparison

Compare VGZ & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vista Gold Corp

VGZ

Vista Gold Corp

HOLD

Current Price

$1.68

Market Cap

316.8M

Sector

N/A

ML Signal

HOLD

Logo SIGA Technologies Inc.

SIGA

SIGA Technologies Inc.

HOLD

Current Price

$3.33

Market Cap

309.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VGZ
SIGA
Founded
1983
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
316.8M
309.8M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
VGZ
SIGA
Price
$1.68
$3.33
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$3.75
N/A
AVG Volume (30 Days)
1.7M
800.2K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
13.24%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$224.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$3.02
52 Week High
$3.13
$9.62

Technical Indicators

Market Signals
Indicator
VGZ
SIGA
Relative Strength Index (RSI) 40.83 35.70
Support Level $1.46 N/A
Resistance Level $1.89 $4.84
Average True Range (ATR) 0.09 0.17
MACD 0.02 -0.01
Stochastic Oscillator 57.58 34.53

Price Performance

Historical Comparison
VGZ
SIGA

About VGZ Vista Gold Corp

Vista Gold Corp operates as a development-stage company in the gold mining industry. Its flagship asset is the Mt Todd Gold Project, a development-stage gold deposit located in the Tier-1 jurisdiction of Northern Territory, Australia. Mt Todd offers a large gold mineral reserve, development optionality, expansion opportunities, exploration upside, local infrastructure, community support, and demonstrated economic feasibility. It operates in one reportable segment, consisting of acquisition, exploration and evaluation activities which are focused on Australia.

About SIGA SIGA Technologies Inc.

SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.

Share on Social Networks: